Bausch + Lomb is a renowned eye health company based in the United States. The company was founded in 1853 by John Jacob Bausch and Henry Lomb, making it one of the oldest and most respected eye care brands in the world. Bausch + Lomb is headquartered in Bridgewater, New Jersey.

The company offers a wide range of products and services designed to meet various eye care needs. Their main product categories include contact lenses, lens care solutions, and ophthalmic pharmaceuticals. Bausch + Lomb is known for its high-quality contact lenses, such as daily disposables, monthly disposables, toric lenses, and multifocal lenses.

They also provide a wide range of lens care solutions, including disinfecting solutions and lubricating eye drops. Additionally, Bausch + Lomb offers pharmaceutical products for both prescription and over-the-counter use. Bausch + Lomb operates on a global scale, with a presence in more than 100 countries.

The company has numerous subsidiaries and joint ventures, including Bausch + Lomb Surgical, which specializes in ophthalmic surgical products, and Bausch Health Companies Inc., a pharmaceutical company. Bausch + Lomb has also established partnerships with medical institutions and research organizations to drive innovation in eye health. In terms of market position, Bausch + Lomb is a significant player in the eye care industry.

With global sales reaching billions of dollars annually, the company competes with other major eye health brands and holds a strong market share. Bausch + Lomb's commitment to innovation, research, and customer satisfaction has contributed to its reputation and success in the industry. Over the years, Bausch + Lomb has experienced various major events, achievements, and changes in its strategy.

One notable event was its acquisition by Valeant Pharmaceuticals International in 2013, which led to the establishment of Bausch Health Companies Inc. This acquisition further enhanced Bausch + Lomb's global presence and allowed for greater investment in research and development. As for the company's current status, Bausch + Lomb continues to prioritize innovation and technology advancement to deliver state-of-the-art eye care solutions.

The company regularly introduces new products and enhances its existing lineup to meet the evolving needs of consumers. Bausch + Lomb remains committed to providing exceptional eye care across the globe and is dedicated to addressing the vision challenges of millions of people